 MedPage Today | Thrombosis Risk Lower with Xience Stent MedPage Today By Todd Neale, Senior Staff Writer, MedPage Today This study found that in the first two years after implantation, cobalt-chromium everolimus-eluting stents (Xience) had lower rates of stent thrombosis than bare-metal stents. Note that cobalt-chromium ... Large Meta-Analysis Finds Very Low Thrombosis Rates for Xience Stent Drug-Eluting Stents Reduce Risk of Thrombosis Stent Wars: DES best bare metal stents |
